244 related articles for article (PubMed ID: 10623433)
61. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
62. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis.
Barak V; Selmi C; Schlesinger M; Blank M; Agmon-Levin N; Kalickman I; Gershwin ME; Shoenfeld Y
J Autoimmun; 2009; 33(3-4):178-82. PubMed ID: 19846277
[TBL] [Abstract][Full Text] [Related]
63. Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?
Lissoni P; Brivio F; Viviani S; Fumagalli L
J Biol Regul Homeost Agents; 1999; 13(2):110-4. PubMed ID: 10503734
[TBL] [Abstract][Full Text] [Related]
64. [Serum levels of soluble interleukin-2 receptor in alcoholic patients].
Sopeña B; Fernández-Rodríguez CM; Martínez Vázquez C; Méndez MX; de la Fuente J; Freire M; Arnillas E; Outon A
An Med Interna; 1998 Apr; 15(4):189-93. PubMed ID: 9608061
[TBL] [Abstract][Full Text] [Related]
65. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
Dejica D; Treichel U; Pár A; Chira O; Meyer zum Büschenfelde KH
Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
[TBL] [Abstract][Full Text] [Related]
66. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
[TBL] [Abstract][Full Text] [Related]
67. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
[TBL] [Abstract][Full Text] [Related]
68. Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C.
Garyfallos A; Raptopoulou-Gigi M; Orphanou H; Spaia S; Petridou P; Vayionas G
J Investig Allergol Clin Immunol; 1995; 5(5):255-8. PubMed ID: 8574431
[TBL] [Abstract][Full Text] [Related]
69. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis.
Alberti A; Chemello L; Fattovich G; Pontisso P; Semenzato G; Colletta C; Vinante F; Pizzolo G
Dig Dis Sci; 1989 Oct; 34(10):1559-63. PubMed ID: 2507263
[TBL] [Abstract][Full Text] [Related]
70. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases].
Tada A; Kawahara S; Horita N; Horiba A; Tamaoki A; Okada C; Mishima Y; Soda R; Takahashi K
Kekkaku; 1999 Jun; 74(6):499-505. PubMed ID: 10423961
[TBL] [Abstract][Full Text] [Related]
71. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
Janczewska-Kazek E; Marek B; Kajdaniuk D; Borgiel-Marek H
World J Gastroenterol; 2006 Feb; 12(6):961-5. PubMed ID: 16521228
[TBL] [Abstract][Full Text] [Related]
72. Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations.
Alexander AG; Barnes NC; Kay AB; Corrigan CJ
Eur Respir J; 1995 Apr; 8(4):574-8. PubMed ID: 7664856
[TBL] [Abstract][Full Text] [Related]
73. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.
Grimm EA; Smid CM; Lee JJ; Tseng CH; Eton O; Buzaid AC
Clin Cancer Res; 2000 Oct; 6(10):3895-903. PubMed ID: 11051235
[TBL] [Abstract][Full Text] [Related]
74. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis.
Caforio AL; Goldman JH; Baig MK; Mahon NJ; Haven AJ; Souberbielle BE; Holt DW; Dalgleish AG; McKenna WJ
Eur J Heart Fail; 2001 Mar; 3(2):155-63. PubMed ID: 11246052
[TBL] [Abstract][Full Text] [Related]
75. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
Buchwald D; Wener MH; Pearlman T; Kith P
J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
[TBL] [Abstract][Full Text] [Related]
76. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia.
Cimino G; Annino L; Giona F; Sgadari C; Di Gregorio AO; Cava MC; Cimino G; Mandelli F
Leukemia; 1991 Jul; 5(7):602-5. PubMed ID: 2072745
[TBL] [Abstract][Full Text] [Related]
77. Serological immunomarkers in cutaneous T cell lymphoma.
Hassel JC; Meier R; Joller-Jemelka H; Burg G; Dummer R
Dermatology; 2004; 209(4):296-300. PubMed ID: 15539892
[TBL] [Abstract][Full Text] [Related]
78. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2.
Lissoni P; Tisi E; Brivio F; Barni S; Rovelli F; Perego M; Tancini G
Eur J Cancer; 1991; 27(8):1014-6. PubMed ID: 1832885
[TBL] [Abstract][Full Text] [Related]
79. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
80. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
